Edward L. Michael - May 27, 2022 Form 4 Insider Report for QUIDEL CORP /DE/ (QDEL)

Role
Director
Signature
/s/ Phillip S. Askim, attorney-in-fact for Edward L. Michael
Stock symbol
QDEL
Transactions as of
May 27, 2022
Transactions value $
$0
Form type
4
Date filed
6/1/2022, 04:23 PM
Previous filing
May 20, 2022
Next filing
Jun 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QDEL Common Stock Disposed to Issuer -9.1K -100% 0 May 27, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QDEL Restricted Stock Units Disposed to Issuer $0 -1.14K -100% $0.00* 0 May 27, 2022 Common Stock 1.14K Direct F2, F3, F4
transaction QDEL Restricted Stock Units Disposed to Issuer $0 -341 -100% $0.00* 0 May 27, 2022 Common Stock 341 Direct F2, F3, F4
transaction QDEL Restricted Stock Units Disposed to Issuer $0 -356 -100% $0.00* 0 May 27, 2022 Common Stock 356 Direct F2, F3, F4
transaction QDEL Restricted Stock Units Disposed to Issuer $0 -106 -100% $0.00* 0 May 27, 2022 Common Stock 106 Direct F2, F3, F4
transaction QDEL Restricted Stock Units Disposed to Issuer $0 -555 -100% $0.00* 0 May 27, 2022 Common Stock 555 Direct F2, F3, F4
transaction QDEL Restricted Stock Units Disposed to Issuer $0 -166 -100% $0.00* 0 May 27, 2022 Common Stock 166 Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Edward L. Michael is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho.
F2 Each restricted stock unit represents the right to receive one share of Quidel common stock.
F3 Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).
F4 Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.